Dariusz Świerczewski

Recent publications · Crossref

5 total works indexed

1. A global reference for human genetic variation

   · 2015 · cited 17,368x

2. 2018 ESC/EACTS Guidelines on myocardial revascularization

   · 2018 · cited 5,451x

3. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

   · 2017 · cited 3,848x

4. Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

   · 2018 · cited 3,062x

5. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,777x

via Crossref · CC0